# 2026-06521: Lab Seeks Approval to Import Obscure Synthetic Drug Substance

2026-06521, Importer of Controlled Substances Application: Lipomed/LGC Standards, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-04-03, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 4, 2026. Such persons may also file a written request for a hearing on the application on or before May 4, 2026.; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-06521
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-06521
- Title: Importer of Controlled Substances Application: Lipomed/LGC Standards
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 16969
- Published: 2026-04-03
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before May 4, 2026. Such persons may also file a written request for a hearing on the application on or before May 4, 2026.
- Comments close: 2026-05-04
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Lab Seeks Approval to Import Obscure Synthetic Drug Substance

## Summary

Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.

## Abstract

Lipomed/LGC Standards has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Importer Seeks to Supply Analytical Standards: benefit, low. On February 11, 2026, Lipomed/LGC Standards applied to be registered to import many Schedule I and II controlled substances (examples include 3-Fluoro-N-methylcathinone, cathinone, methcathinone, mephedrone, GHB, fentanyl-related compounds, LSD, psilocybin, and many others). The company says it pla…
- Import Registration Excludes Finished Dosage Forms: cost, medium. The notice says placement of these drug codes on the company's registration does not automatically approve later permits, and authorization will not extend to the import of Food and Drug Administration‑approved or non‑approved finished dosage forms for commercial sale. Permit approvals will only oc…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2026-06521 on federalregister.gov](https://www.federalregister.gov/documents/2026/04/03/2026-06521/importer-of-controlled-substances-application-lipomedlgc-standards)
- [2026-06521 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-04-03/pdf/2026-06521.pdf)

## Related
- [Previous: 2026-06520, Importer of Controlled Substances Application: Blue Rabbit Veterinary LLC](https://policyrisk.com/federal-register/2026-06520)
- [Next: 2026-06522, Bulk Manufacturer of Controlled Substances Application: Research Triangle Insti…](https://policyrisk.com/federal-register/2026-06522)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-06521 (as of 2026-06-08).
